<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36736191</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1879-1360</ISSN><JournalIssue CitedMedium="Internet"><Volume>166</Volume><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of psychosomatic research</Title><ISOAbbreviation>J Psychosom Res</ISOAbbreviation></Journal><ArticleTitle>Persistent physical symptoms after COVID-19 infection and the risk of Somatic Symptom Disorder.</ArticleTitle><Pagination><StartPage>111172</StartPage><MedlinePgn>111172</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jpsychores.2023.111172</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0022-3999(23)00027-2</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Evidence shows that many patients with COVID-19 present persistent symptoms after the acute infection. Some patients may be at a high risk of developing Somatic Symptom Disorder (SSD), in which persistent symptoms are accompanied by excessive and disproportionate health-related thoughts, feelings and behaviors regarding these symptoms. This study assessed the frequency of persistent physical symptoms and SSD and their associated factors in patients with confirmed COVID-19.</AbstractText><AbstractText Label="METHODS">We conducted a longitudinal retrospective study after the first two French lockdowns at the Lille University Hospital (France), including all patients with confirmed COVID-19. Persistent physical symptoms and excessive preoccupations for these symptoms were measured 8 to 10&#xa0;months after the onset of COVID-19. The combination of the Patient Health Questionnaire-15 and the Somatic Symptom Disorder-B Criteria Scale was used to identify the individuals likely to present with SSD. Two linear regression models were performed to identify sociodemographic and medical risk factors of SSD.</AbstractText><AbstractText Label="RESULTS">Among the 377 patients with a laboratory-confirmed diagnosis, 220 (58.4%) completed the questionnaires. Sixty-five percent of the 220 included patients required hospitalization, 53.6% presented at least one persistent physical symptom and 10.4% were considered to present SSD. Female sex, older age, infection during the second wave and having probable PTSD were significantly associated with the severity of SSD and SSD was associated with a significantly higher healthcare use.</AbstractText><AbstractText Label="CONCLUSIONS">The identification of SSD should encourage clinicians to move beyond the artificial somatic/psychiatric dualism and contribute to a better alliance based on multi-disciplinary care.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Horn</LastName><ForeName>Mathilde</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience &amp; Cognition, F-59000 Lille, France; CHU Lille, P&#xf4;le de Psychiatrie, F-59000 Lille, France. Electronic address: horn.mathilde@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wathelet</LastName><ForeName>Marielle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience &amp; Cognition, F-59000 Lille, France; CHU Lille, P&#xf4;le de Psychiatrie, F-59000 Lille, France; Centre National de Ressources et de R&#xe9;silience Lille-Paris (CN2R), Lille F-59000, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amad</LastName><ForeName>Ali</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience &amp; Cognition, F-59000 Lille, France; CHU Lille, P&#xf4;le de Psychiatrie, F-59000 Lille, France; Department of Neuroimaging, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martign&#xe8;ne</LastName><ForeName>Niels</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Centre National de Ressources et de R&#xe9;silience Lille-Paris (CN2R), Lille F-59000, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lathiere</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>CHU Lille, P&#xf4;le de Psychiatrie, F-59000 Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khelfaoui</LastName><ForeName>Kam&#xe9;lia</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>CHU Lille, P&#xf4;le de Psychiatrie, F-59000 Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rousselle</LastName><ForeName>Margot</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CHU Lille, P&#xf4;le de Psychiatrie, F-59000 Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Qaoubii</LastName><ForeName>Ouma&#xef;ma</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>CHU Lille, P&#xf4;le de Psychiatrie, F-59000 Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vuotto</LastName><ForeName>Fanny</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Service de Maladies Infectieuses et Tropicales, CHU Lille, Equipe OpInfIELD Infections Opportunistes, Immunit&#xe9;, Environnement &amp; Maladies Pulmonaires, Centre Infection et Inflammation, Inserm U1019; CNRS UMR9017; Universit&#xe9; de Lille, Institut Pasteur de Lille, CHU de Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faure</LastName><ForeName>Karine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Service de Maladies Infectieuses et Tropicales, CHU Lille, Equipe OpInfIELD Infections Opportunistes, Immunit&#xe9;, Environnement &amp; Maladies Pulmonaires, Centre Infection et Inflammation, Inserm U1019; CNRS UMR9017; Universit&#xe9; de Lille, Institut Pasteur de Lille, CHU de Lille, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Creupelandt</LastName><ForeName>Coralie</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Centre National de Ressources et de R&#xe9;silience Lille-Paris (CN2R), Lille F-59000, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaiva</LastName><ForeName>Guillaume</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience &amp; Cognition, F-59000 Lille, France; CHU Lille, P&#xf4;le de Psychiatrie, F-59000 Lille, France; Centre National de Ressources et de R&#xe9;silience Lille-Paris (CN2R), Lille F-59000, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fovet</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience &amp; Cognition, F-59000 Lille, France; CHU Lille, P&#xf4;le de Psychiatrie, F-59000 Lille, France; Centre National de Ressources et de R&#xe9;silience Lille-Paris (CN2R), Lille F-59000, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Hondt</LastName><ForeName>Fabien</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Univ. Lille, Inserm, CHU Lille, U1172 - LilNCog - Lille Neuroscience &amp; Cognition, F-59000 Lille, France; CHU Lille, P&#xf4;le de Psychiatrie, F-59000 Lille, France; Centre National de Ressources et de R&#xe9;silience Lille-Paris (CN2R), Lille F-59000, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Psychosom Res</MedlineTA><NlmUniqueID>0376333</NlmUniqueID><ISSNLinking>0022-3999</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013001" MajorTopicYN="N">Somatoform Disorders</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071896" MajorTopicYN="Y">Medically Unexplained Symptoms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID, post-acute sequelae of COVID-19</Keyword><Keyword MajorTopicYN="N">Post-COVID condition</Keyword><Keyword MajorTopicYN="N">Post-traumatic stress disorder</Keyword><Keyword MajorTopicYN="N">Somatic Symptom Disorder</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>1</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>3</Day><Hour>18</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>1</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36736191</ArticleId><ArticleId IdType="pmc">PMC9876030</ArticleId><ArticleId IdType="doi">10.1016/j.jpsychores.2023.111172</ArticleId><ArticleId IdType="pii">S0022-3999(23)00027-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long covid-mechanisms, risk factors, and management. BMJ. 2021;374 doi: 10.1136/BMJ.N1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ.N1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaya J.M., Rojas M., Salinas M.L., Rodr&#xed;guez Y., Roa G., Lozano M., Rodr&#xed;guez-Jim&#xe9;nez M., Montoya N., Zapata E., Monsalve D.M., Acosta-Ampudia Y., Ram&#xed;rez-Santana C. Post-COVID syndrome. A case series and comprehensive review. Autoimmun. Rev. 2021;20 doi: 10.1016/J.AUTREV.2021.102947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.AUTREV.2021.102947</ArticleId><ArticleId IdType="pmc">PMC8428988</ArticleId><ArticleId IdType="pubmed">34509649</ArticleId></ArticleIdList></Reference><Reference><Citation>Berenguera A., Jacques-Avi&#xf1;&#xf3; C., Medina-Perucha L., Puente D. Long term consequences of COVID-19. Eur. J. Intern. Med. 2021;92:34&#x2013;35. doi: 10.1016/J.EJIM.2021.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.EJIM.2021.08.022</ArticleId><ArticleId IdType="pmc">PMC8410511</ArticleId><ArticleId IdType="pubmed">34509350</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Zhao N. Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a web-based cross-sectional survey. Psychiatry Res. 2020;288 doi: 10.1016/j.psychres.2020.112954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2020.112954</ArticleId><ArticleId IdType="pmc">PMC7152913</ArticleId><ArticleId IdType="pubmed">32325383</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., Ahluwalia N., Bikdeli B., Dietz D., Der-Nigoghossian C., Liyanage-Don N., Rosner G.F., Bernstein E.J., Mohan S., Beckley A.A., Seres D.S., Choueiri T.K., Uriel N., Ausiello J.C., Accili D., Freedberg D.E., Baldwin M., Schwartz A., Brodie D., Garcia C.K., Elkind M.S.V., Connors J.M., Bilezikian J.P., Landry D.W., Wan E.Y. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/S41591-021-01283-Z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41591-021-01283-Z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M., Braillard O., Chappuis F., Courvoisier D.S., Guessous I. Prevalence of symptoms more than seven months after diagnosis of symptomatic COVID-19 in an outpatient setting. Ann. Intern. Med. 2021;174:1252&#x2013;1260. doi: 10.7326/M21-0878.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-0878</ArticleId><ArticleId IdType="pmc">PMC8280535</ArticleId><ArticleId IdType="pubmed">34224254</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaya J.M., Rojas M., Salinas M.L., Rodr&#xed;guez Y., Roa G., Lozano M., Rodr&#xed;guez-Jim&#xe9;nez M., Montoya N., Zapata E., Monsalve D.M., Acosta-Ampudia Y., Ram&#xed;rez-Santana C. Post-COVID syndrome. A case series and comprehensive review. Autoimmun. Rev. 2021;20 doi: 10.1016/J.AUTREV.2021.102947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.AUTREV.2021.102947</ArticleId><ArticleId IdType="pmc">PMC8428988</ArticleId><ArticleId IdType="pubmed">34509649</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-Las-Pen&#xe3;s C., Palacios-Cen&#xe3; D., G&#xf3;mez-Mayordomo V., Palacios-Cen&#xe3; M., Rodr&#xed;guez-Jim&#xe9;nez J., De-La-Llave-Rinc&#xf3;n A.I., Velasco-Arribas M., Fuensalida-Novo S., Ambite-Quesada S., Guijarro C., Cuadrado M.L., Florencio L.L., Arias-Naval&#xf3;n J.A., Ortega-Santiago R., Elvira-Mart&#xed;nez C.M., Molina-Trigueros L.J., Torres-Macho J., Sebasti&#xe1;n-Viana T., Canto-Diez M.G., Cigar&#xe1;n-M&#xe9;ndez M., Hern&#xe1;ndez-Barrera V., Arendt-Nielsen L. Fatigue and dyspnoea as main persistent post-COVID-19 symptoms in previously hospitalized patients: related functional limitations and disability. Respiration. 2021 doi: 10.1159/000518854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000518854</ArticleId><ArticleId IdType="pmc">PMC8678253</ArticleId><ArticleId IdType="pubmed">34569550</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., Ahluwalia N., Bikdeli B., Dietz D., Der-Nigoghossian C., Liyanage-Don N., Rosner G.F., Bernstein E.J., Mohan S., Beckley A.A., Seres D.S., Choueiri T.K., Uriel N., Ausiello J.C., Accili D., Freedberg D.E., Baldwin M., Schwartz A., Brodie D., Garcia C.K., Elkind M.S.V., Connors J.M., Bilezikian J.P., Landry D.W., Wan E.Y. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/S41591-021-01283-Z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41591-021-01283-Z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta J., Wiernik E., Robineau O., Carrat F., Touvier M., Severi G., de Lamballerie X., Blanch&#xe9; H., Deleuze J.-F., Gouraud C., Hoertel N., Ranque B., Goldberg M., Zins M., Lemogne C., Sant&#xe9;, Pratiques, Relations et In&#xe9;galit&#xe9;s Sociales en Population G&#xe9;n&#xe9;rale Pendant la Crise COVID-19&#x2013;S&#xe9;rologie (SAPRIS-SERO) Study Group Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Intern. Med. 2021 doi: 10.1001/JAMAINTERNMED.2021.6454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMAINTERNMED.2021.6454</ArticleId><ArticleId IdType="pmc">PMC8576624</ArticleId><ArticleId IdType="pubmed">34747982</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet The. Facing up to long COVID. Lancet. 2020;396:1861. doi: 10.1016/S0140-6736(20)32662-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32662-3</ArticleId><ArticleId IdType="pmc">PMC7834723</ArticleId><ArticleId IdType="pubmed">33308453</ArticleId></ArticleIdList></Reference><Reference><Citation>Horn M., Fovet T., Vaiva G., D&#x2019;Hondt F., Amad A. Somatic symptom disorders and long COVID: a critical but overlooked topic. Gen. Hosp. Psychiatry. 2021;72:149&#x2013;150. doi: 10.1016/J.GENHOSPPSYCH.2021.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.GENHOSPPSYCH.2021.06.007</ArticleId><ArticleId IdType="pmc">PMC8233051</ArticleId><ArticleId IdType="pubmed">34215435</ArticleId></ArticleIdList></Reference><Reference><Citation>Willis C., Chalder T. Concern for Covid-19 cough, fever and impact on mental health. What about risk of somatic symptom disorder? J. Ment. Health. 2021;30:551&#x2013;555. doi: 10.1080/09638237.2021.1875418.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09638237.2021.1875418</ArticleId><ArticleId IdType="pubmed">33522343</ArticleId></ArticleIdList></Reference><Reference><Citation>American Psychiatric Association . Fifth edition. American Psychiatric Publishing; 2013. Diagnostic and Statistical Manual of Mental Disorders (DSM-5)</Citation></Reference><Reference><Citation>H&#xfc;sing P., Bassler M., L&#xf6;we B., Koch S., Toussaint A. Validity and sensitivity to change of the somatic symptom disorder-B criteria scale (SSD-12) in a clinical population. Gen. Hosp. Psychiatry. 2018;55:20&#x2013;26. doi: 10.1016/J.GENHOSPPSYCH.2018.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.GENHOSPPSYCH.2018.08.006</ArticleId><ArticleId IdType="pubmed">30232051</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson S.L., Menkes D.B. Long covid: reshaping conversations about medically unexplained symptoms. BMJ. 2021;374 doi: 10.1136/BMJ.N1859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/BMJ.N1859</ArticleId><ArticleId IdType="pubmed">34321219</ArticleId></ArticleIdList></Reference><Reference><Citation>Henningsen P., G&#xfc;ndel H., Kop W.J., L&#xf6;we B., Martin A., Rief W., Rosmalen J.G.M., Schr&#xf6;der A., van der Feltz-Cornelis C., van den Bergh O. Persistent physical symptoms as perceptual dysregulation: a neuropsychobehavioral model and its clinical implications. Psychosom. Med. 2018;80:422&#x2013;431. doi: 10.1097/PSY.0000000000000588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0000000000000588</ArticleId><ArticleId IdType="pubmed">29621046</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;we B., Gerloff C. Functional somatic symptoms across cultures: perceptual and health care issues. Psychosom. Med. 2018;80:412&#x2013;415. doi: 10.1097/PSY.0000000000000594.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0000000000000594</ArticleId><ArticleId IdType="pubmed">29677034</ArticleId></ArticleIdList></Reference><Reference><Citation>Toussaint A., H&#xfc;sing P., Kohlmann S., L&#xf6;we B. Detecting DSM-5 somatic symptom disorder: criterion validity of the patient health questionnaire-15 (PHQ-15) and the somatic symptom scale-8 (SSS-8) in combination with the somatic symptom disorder - B criteria scale (SSD-12) Psychol. Med. 2020;50:324&#x2013;333. doi: 10.1017/S003329171900014X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S003329171900014X</ArticleId><ArticleId IdType="pubmed">30729902</ArticleId></ArticleIdList></Reference><Reference><Citation>Horn M., Wathelet M., Fovet T., Amad A., Vuotto F., Faure K., Astier T., No&#xeb;l H., Henry M., Duhem S., Vaiva G., D&#x2019;Hondt F. Is COVID-19 associated with posttraumatic stress disorder? J. Clin. Psychiatry. 2020;82 doi: 10.4088/JCP.20M13641.</Citation><ArticleIdList><ArticleId IdType="doi">10.4088/JCP.20M13641</ArticleId><ArticleId IdType="pubmed">33296149</ArticleId></ArticleIdList></Reference><Reference><Citation>Liyanage-Don N.A., Cornelius T., Sanchez J.E., Trainor A., Moise N., Wainberg M., Kronish I.M. Psychological distress, persistent physical symptoms, and perceived recovery after COVID-19 illness. J. Gen. Intern. Med. 2021;36:2525&#x2013;2527. doi: 10.1007/S11606-021-06855-W.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S11606-021-06855-W</ArticleId><ArticleId IdType="pmc">PMC8118366</ArticleId><ArticleId IdType="pubmed">33987793</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiaoming X., Ming A., Su H., Wo W., Jianmei C., Qi Z., Hua H., Xuemei L., Lixia W., Jun C., Lei S., Zhen L., Lian D., Jing L., Handan Y., Haitang Q., Xiaoting H., Xiaorong C., Ran C., Qinghua L., Xinyu Z., Jian T., Jing T., Guanghua J., Zhiqin H., Nkundimana B., Li K. The psychological status of 8817 hospital workers during COVID-19 epidemic: a cross-sectional study in Chongqing. J. Affect. Disord. 2020;276:555&#x2013;561. doi: 10.1016/J.JAD.2020.07.092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.JAD.2020.07.092</ArticleId><ArticleId IdType="pmc">PMC7369013</ArticleId><ArticleId IdType="pubmed">32871686</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahini N., Ghasemzadeh M., Javan M., Salimi Z. Evaluation of the COVID-19 pandemic effect on the development of somatic symptoms in patients with mood disorders: a case-control study. New Microbes New Infect. 2021;43 doi: 10.1016/J.NMNI.2021.100917.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.NMNI.2021.100917</ArticleId><ArticleId IdType="pmc">PMC8463032</ArticleId><ArticleId IdType="pubmed">34603735</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Shi Y., Jing P., Zhan P., Fang Y., Wang F. Posttraumatic stress disorder symptoms in healthcare workers after the peak of the COVID-19 outbreak: a survey of a large tertiary care hospital in Wuhan. Psychiatry Res. 2020;294 doi: 10.1016/J.PSYCHRES.2020.113541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/J.PSYCHRES.2020.113541</ArticleId><ArticleId IdType="pmc">PMC7585629</ArticleId><ArticleId IdType="pubmed">33128999</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K., Spitzer R.L., Williams J.B.W. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom. Med. 2002;64:258&#x2013;266. doi: 10.1097/00006842-200203000-00008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006842-200203000-00008</ArticleId><ArticleId IdType="pubmed">11914441</ArticleId></ArticleIdList></Reference><Reference><Citation>Toussaint A., Murray A.M., Voigt K., Herzog A., Gierk B., Kroenke K., Rief W., Henningsen P., L&#xf6;we B. Development and validation of the somatic symptom disorder-B criteria scale (SSD-12) Psychosom. Med. 2016;78:5&#x2013;12. doi: 10.1097/PSY.0000000000000240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0000000000000240</ArticleId><ArticleId IdType="pubmed">26461855</ArticleId></ArticleIdList></Reference><Reference><Citation>Weathers F.W., Litz B., Herman D., Huska J., Keane T. 1993. Paper Presented at the Annual Convention of the International Society for Traumatic Stress Studies. in: San Antonio.</Citation></Reference><Reference><Citation>Nehme M., Braillard O., Chappuis F., Courvoisier D.S., Guessous I. Prevalence of symptoms more than seven months after diagnosis of symptomatic COVID-19 in an outpatient setting. Ann. Intern. Med. 2021;174:1252&#x2013;1260. doi: 10.7326/M21-0878.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M21-0878</ArticleId><ArticleId IdType="pmc">PMC8280535</ArticleId><ArticleId IdType="pubmed">34224254</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Souza R.S., Hooten W.M.  StatPearls; 2021. Somatic Syndrome Disorders.https://pubmed.ncbi.nlm.nih.gov/30335286/ (accessed December 8, 2021)</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Klem F., Wadhwa A., Prokop L.J., Sundt W.J., Farrugia G., Camilleri M., Singh S., Grover M. Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: a systematic review and meta-analysis. Gastroenterology. 2017;152:1042&#x2013;1054.e1. doi: 10.1053/J.GASTRO.2016.12.039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/J.GASTRO.2016.12.039</ArticleId><ArticleId IdType="pmc">PMC5367939</ArticleId><ArticleId IdType="pubmed">28069350</ArticleId></ArticleIdList></Reference><Reference><Citation>Svendsen A.T., Bytzer P., Engsbro A.L. Systematic review with meta-analyses: does the pathogen matter in post-infectious irritable bowel syndrome? Scand. J. Gastroenterol. 2019;54:546&#x2013;562. doi: 10.1080/00365521.2019.1607897.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365521.2019.1607897</ArticleId><ArticleId IdType="pubmed">31112663</ArticleId></ArticleIdList></Reference><Reference><Citation>Janiri D., Kotzalidis G.D., Sani G. Improving the assessment of COVID-19-associated posttraumatic stress disorder-reply. JAMA Psychiatry. 2021;78:795&#x2013;796. doi: 10.1001/JAMAPSYCHIATRY.2021.1126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMAPSYCHIATRY.2021.1126</ArticleId><ArticleId IdType="pubmed">34076674</ArticleId></ArticleIdList></Reference><Reference><Citation>Afari N., Ahumada S.M., Wright L.J., Mostoufi S., Golnari G., Reis V., Cuneo J.G. Psychological trauma and functional somatic syndromes: a systematic review and meta-analysis. Psychosom. Med. 2014;76:2&#x2013;11. doi: 10.1097/PSY.0000000000000010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0000000000000010</ArticleId><ArticleId IdType="pmc">PMC3894419</ArticleId><ArticleId IdType="pubmed">24336429</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta M.A. Review of somatic symptoms in post-traumatic stress disorder. Int. Rev. Psychiatry. 2013;25:86&#x2013;99. doi: 10.3109/09540261.2012.736367.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09540261.2012.736367</ArticleId><ArticleId IdType="pubmed">23383670</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig A.D. How do you feel--now? The anterior insula and human awareness. Nat. Rev. Neurosci. 2009;10:59&#x2013;70. doi: 10.1038/NRN2555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/NRN2555</ArticleId><ArticleId IdType="pubmed">19096369</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurlansik S.L., Maffei M.S. Somatic symptom disorder. Am. Fam. Physician. 2016;93:49&#x2013;54. www.aafp.org/afp (accessed December 15, 2021)</Citation><ArticleIdList><ArticleId IdType="pubmed">26760840</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijeratne C., Brodaty H., Hickie I. The neglect of somatoform disorders by old age psychiatry: some explanations and suggestions for future research. Int. J. Geriatr. Psychiatry. 2003;18:812&#x2013;819. doi: 10.1002/GPS.925.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/GPS.925</ArticleId><ArticleId IdType="pubmed">12949849</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulsant B.H., Ganguli M. Epidemiology and diagnosis of depression in late life. J. Clin. Psychiatry. 1999;60(Suppl. 20):9&#x2013;15. https://pubmed.ncbi.nlm.nih.gov/10513852/ (accessed December 15, 2021)</Citation><ArticleIdList><ArticleId IdType="pubmed">10513852</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheehan B., Philpot M., Banerjee S. Attributions of physical symptoms in patients of an old age psychiatry service. Int. J. Geriatr. Psychiatry. 2002;17:61&#x2013;64. doi: 10.1002/GPS.520.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/GPS.520</ArticleId><ArticleId IdType="pubmed">11802232</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherlinger M., Lemogne C., Felten R., Sibilia J. Excess of post-acute sequelae of COVID-19 after the first wave of the pandemic. Infect. Dis. Ther. 2022;11:2279. doi: 10.1007/S40121-022-00698-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/S40121-022-00698-6</ArticleId><ArticleId IdType="pmc">PMC9511440</ArticleId><ArticleId IdType="pubmed">36156194</ArticleId></ArticleIdList></Reference><Reference><Citation>Amad A., Fovet T., Geoffroy P.A. Keep calm: psychiatric disorders are organic! The power of words in medicine. Aust N Z J Psychiatry. 2016;50:100&#x2013;101. doi: 10.1177/0004867415601730.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0004867415601730</ArticleId><ArticleId IdType="pubmed">26316003</ArticleId></ArticleIdList></Reference><Reference><Citation>Horn M., Fovet T., Vaiva G., D&#x2019;Hondt F., Amad A. Somatic symptom disorders and long COVID: a critical but overlooked topic. Gen. Hosp. Psychiatry. 2021;72:149&#x2013;150. doi: 10.1016/j.genhosppsych.2021.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genhosppsych.2021.06.007</ArticleId><ArticleId IdType="pmc">PMC8233051</ArticleId><ArticleId IdType="pubmed">34215435</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleinst&#xe4;uber M., Lambert M.J., Hiller W. Early response in cognitive-behavior therapy for syndromes of medically unexplained symptoms. BMC Psychiatry. 2017;17 doi: 10.1186/S12888-017-1351-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/S12888-017-1351-X</ArticleId><ArticleId IdType="pmc">PMC5445472</ArticleId><ArticleId IdType="pubmed">28545580</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>